Keynote special: BioNTech

06-Apr-2021 11:47

We are very pleased to announce the first keynote. Holger Kissel, Vice President Business Alliances of BioNTech will open the 2nd conference day (April 29) with his presentation. As a result of the pandemic, BioNTech has become a globally known flagship of the German biotechnology industry virtually overnight. The BioNTech vaccine is key to overcoming the Corona crisis. The company has achieved something unique in many respects: for the first time ever, an mRNA-based vaccine was brought to market approval. And it did so with an incredible effort within just a few months. Holger Kissel will tell us more about the company’s “Lightspeed” journey and its challenges and important milestones. We are looking forward to some exciting insights.

We value your privacy

We and our partners store or access information on devices, such as cookies and process personal data, such as unique identifiers and standard information sent by a device for the purposes described below. You may click to consent to our and our partners’ processing for such purposes. Alternatively, you may click to refuse to consent, or access more detailed information and change your preferences before consenting. Your preferences will apply to this website only. Please note that some processing of your personal data may not require your consent, but you have a right to object to such processing. You can change your preferences at any time by returning to this site or visit our privacy policy.